Researchers developed a simple test that finds the bacteria that cause Rocky Mountain spotted fever in 40 minutes. The test works in two 20-minute steps at room temperature and shows a color change for positives.
Photo by National Institute of Allergy and Infectious Diseases, Unsplash
Cryptococcal meningitis kills many people in Sub‑Saharan Africa and mainly affects people with HIV. A Phase II trial in Lilongwe is testing a sustained‑release flucytosine pellet to make treatment easier, while clinicians warn that early testing and care remain vital.
A 12-year study in southwest Tanzania found that mass treatment for lymphatic filariasis (elephantiasis) was linked to fewer new HIV infections. Researchers say clearing the parasite may reduce HIV risk, but policies have not changed.
Researchers using New Orleans hospital records found people with later-stage syphilis had higher risks of major cardiovascular events, especially when the infection lasted more than a year. The study shows an association but not proof of cause.
European regulators approved Acoziborole, a single-dose oral treatment for sleeping sickness after successful trials in the DRC and Guinea. Sanofi will donate doses to WHO, but national approvals and vector control are still needed to reach elimination goals.
Researchers developed a needle-free spray-mist device to push last-resort antibiotics through the skin into infected tissue. The method aims to treat drug-resistant infections while reducing organ damage linked to intravenous delivery.
Yale researchers imaged the molecular structure of Vibrio cholerae flagella in living bacteria. The study shows how flagella proteins sit inside a hydrophilic sheath and suggests the sheath helps the bacterium move and infect cells.
A study found that adults hospitalised with respiratory syncytial virus (RSV) often had lasting problems. Many patients experienced breathlessness and trouble with daily activities for months, and some stayed unwell for up to a year.
Researchers presented four new AI approaches for detecting and monitoring TB at the Union World Conference on Lung Health in Copenhagen (18–21 November). The tools include breath analysis, cough screening, vulnerability mapping and a chest X‑ray tool for children.
